Funds · 13F filer · Rio De Janeiro, D5

JGP Global Gestao de Recursos Ltda.

$44.8M in 29 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return−4.6%S&P 500 +20.9%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since September 30, 2024: $139 against $130 in the S&P 500.2

JGP Global Gestao de Recursos Ltda.S&P 500 (SPY)
$85$100$19120242026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
Xp Inc - Class ACUSIP G98239109$10.7M23.9%+153.2%
SPYSpdr S&p 500 Etf Trust$7.7M17.2%New
SFTBYSoftbank Group Corp-unsp Adr$4.3M9.5%New
VEONVeon Ltd$3.5M7.8%New
PROSYProsus Nv -spon Adr$3.0M6.7%New
Ataibeckley IncCUSIP 04650F101$2.6M5.9%New
ECHOEchostar Corp-a$2.2M4.9%New
CKHUYCk Hutchison Holdin-unsp Adr$1.5M3.4%New
ITUBItau Unibanco Hldng-pref Adr$1.4M3.1%New
LLYEli Lilly & Co$1.3M2.9%−10.8%
ABBVAbbvie Inc$722K1.6%−6.5%
INCYIncyte Corp$637K1.4%
JNJJohnson & Johnson$601K1.3%+11.1%
UNHUnitedhealth Group Inc$517K1.2%New
ONCBeigene Ltd-adr$488K1.1%
MRKMerck & Co. Inc.$433K1.0%New
STMStmicroelectronics Nv-ny Shs$401K0.9%New
VRTXVertex Pharmaceuticals Inc$360K0.8%+35.0%
BMYBristol-myers Squibb Co$355K0.8%
RVMDRevolution Medicines Inc$333K0.7%New
GILDGilead Sciences Inc$270K0.6%−8.3%
TMOThermo Fisher Scientific Inc$268K0.6%−24.1%
ABTAbbott Laboratories$261K0.6%−7.1%
MDGLMadrigal Pharmaceuticals Inc$232K0.5%
ISRGIntuitive Surgical Inc$225K0.5%−24.5%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
LLYEli Lilly & CoJune 30, 2020+630.6%$1.3M
MDGLMadrigal Pharmaceuticals IncDecember 31, 2023+132.1%$232K
ISRGIntuitive Surgical IncJune 30, 2020+109.4%$225K
VRTXVertex Pharmaceuticals IncJune 30, 2020+71.1%$360K
JNJJohnson & JohnsonMarch 31, 2025+53.1%$601K
ONCBeigene Ltd-adrJune 30, 2020+51.3%$488K
INCYIncyte CorpMarch 31, 2021+39.5%$637K
ABBVAbbvie IncMarch 31, 2025+20.1%$722K
Xp Inc - Class ACUSIP G98239109March 31, 2025+18.3%$10.7M
GILDGilead Sciences IncMarch 31, 2025+12.8%$270K

Sold off last quarter

  • Stoneco Ltd-aCUSIP G85158106 was $6.7M
  • Nu Holdings Ltd/cayman Isl-aCUSIP G6683N103 was $3.4M
  • TSMTaiwan Semiconductor-sp Adr was $351K
  • NVDANvidia Corp was $265K
  • MCKMckesson Corp was $246K
  • ZTSZoetis Inc was $212K
  • INSMInsmed Inc was $212K
  • VNETVnet Group Inc-adr was $208K
  • BSXBoston Scientific Corp was $205K

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026−9.6%+14.8%
March 31, 2026−19.5%−4.6%
December 31, 2025+1.8%+2.4%
September 30, 2025+28.8%+7.8%
June 30, 2025+38.0%+10.5%
March 31, 2025+23.8%−4.6%
December 31, 2024−14.7%+2.1%
June 30, 2023+1.6%+8.3%
March 31, 2023−0.4%+7.0%
December 31, 2022−0.3%+7.1%
September 30, 2022+20.5%−5.3%
June 30, 2022−14.4%−16.5%
March 31, 2022+3.1%−4.9%
December 31, 2021−5.7%+10.7%
September 30, 2021−16.4%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1536562
  2. 2
    Filed July 20, 2026 · accession 0001536562-26-000004